Quick Answer
CVS HEALTH Corp reported Cash And Cash Equivalents At Carrying Value of $8.45 billion for the year ending 2025.
- CVS HEALTH Corp showed a decrease of -1.5% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from CVS HEALTH Corp's annual report (Form 10-K), filed with the SEC on February 10, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 16 years of available data (2010 to 2025), CVS HEALTH Corp's Cash And Cash Equivalents At Carrying Value has grown by 492.4%.
- Historical annual values: Fiscal year 2025: $8.45 billion | Fiscal year 2024: $8.59 billion | Fiscal year 2023: $8.20 billion | Fiscal year 2022: $12.95 billion | Fiscal year 2021: $9.41 billion | Fiscal year 2020: $7.85 billion | Fiscal year 2019: $5.68 billion | Fiscal year 2018: $4.06 billion | Fiscal year 2017: $1.70 billion | Fiscal year 2016: $3.37 billion | Fiscal year 2015: $2.46 billion | Fiscal year 2014: $2.48 billion | Fiscal year 2013: $4.09 billion | Fiscal year 2012: $1.38 billion | Fiscal year 2011: $1.41 billion | Fiscal year 2010: $1.43 billion.
- Data sourced from SEC EDGAR public filings as of June 24, 2026.
Last verified: